ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on a Phase 1b Study of Blinatumomab With the Anti-Programmed Cell Death PD-1 Antibody AMG 404 in Adults With R/R B-Cell Precursor ALL
By
ASCO 2022 Conference Coverage
FEATURING
Cristina Papayannidis
By
ASCO 2022 Conference Coverage
FEATURING
Cristina Papayannidis
15 views
June 17, 2022
Comments 0
Login to view comments.
Click here to Login
Leukemia